Exposure–response analysis of endoxifen serum concentrations in early-breast cancer

PURPOSE: Tamoxifen is part of endocrine therapy in breast cancer treatment. Studies have indicated the use of endoxifen concentrations, tamoxifen active metabolite, to guide tamoxifen efficacy. Three endoxifen thresholds have been suggested (5.9 ng/ml, 5.2 ng/ml and 3.3 ng/ml) for therapeutic drug m...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchez-Spitman, Anabel Beatriz, Moes, Dirk-Jan A. R., Swen, Jesse J., Dezentjé, Vincent O., Lambrechts, Diether, Neven, Patrick, Gelderblom, Hans, Guchelaar, Henk-Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305085/
https://www.ncbi.nlm.nih.gov/pubmed/32468081
http://dx.doi.org/10.1007/s00280-020-04089-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305085/
https://www.ncbi.nlm.nih.gov/pubmed/32468081
http://dx.doi.org/10.1007/s00280-020-04089-x

Ejemplares similares